The United States Self-Monitoring Blood Glucose Market is anticipated to cross US$ 4.6 billion by the year-end of 2027.
Large patient pool suffering from diabetes, the rapid uptake of innovative, user–friendly, and technological advancements products, the surge in the aging population, and an upsurge in risk factors that lead to diabetes drive the growth of the U.S self-monitoring blood glucose market.